Similar herpes zoster incidence across Europe: results from a systematic literature review - sprookjes - yvandenbroek - TriplyDB

Similar herpes zoster incidence across Europe: results from a systematic literature review

Similar herpes zoster incidence across Europe: results from a systematic literature review

http://www.wikidata.org/entity/Q26824836

about

Herpes Zoster: the rationale for the introduction of vaccination in Italy Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective Evaluation of efficacy and effectiveness of live attenuated zoster vaccine Reducing the burden of Herpes Zoster in Italy Herpes zoster and postherpetic neuralgia in older adults Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.Risk Factors for Aseptic Meningitis in Herpes Zoster Patients.Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study Systematic review of incidence and complications of herpes zoster: towards a global perspective.Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006.Cost-effectiveness of vaccination against herpes zoster.Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).Disease burden of herpes zoster in Sweden--predominance in the elderly and in women - a register based study The humanistic, economic and societal burden of herpes zoster in Europe: a critical review Evaluation of the economic burden of Herpes Zoster (HZ) infection.Increasing trends of herpes zoster in Australia.Herpes zoster-associated mortality in Europe: a systematic review.Burden of herpes zoster and post-herpetic neuralgia in Sweden.Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France.Herpes zoster and postherpetic neuralgia in Catalonia (Spain)The burden of disease of Herpes Zoster in Tuscany.Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality.Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study.Increasing incidence associated with herpes zoster infection in British Columbia, Canada Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China.Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults.Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort study.Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study.Incidence of herpes zoster in patients with altered immune function.Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly.

P2860

Q26770662-94A5C593-E9DD-468C-A296-071236C6BAB1 Q26781940-DC2B2B9F-9309-4029-B8F2-8A02459868A3 Q26866473-43EBC05A-0F5A-404A-A003-3C741CF8AC88 Q26998625-71366B8B-3492-450C-8CE1-327B9EC150B5 Q28111717-5AD3C720-033D-4BF9-BE52-C25DEB4B7336 Q33578057-C9058377-9C77-4CE4-83CC-2ADE0ABE06A4 Q33626007-99C0C2B7-E076-41BD-BE0E-6581CDBC1523 Q33710635-BE5C1F28-D3B3-4085-B9BC-D7F00D86C7BC Q33776676-9EDA391B-1917-49EA-AF10-2CA421E617E5 Q33795551-0DCE3961-5B4C-4936-BFC0-C7894EF88492 Q33883111-845C9DB7-D639-4DE6-913F-E46F4DCE9572 Q33922078-961747A7-5ADA-4807-AAC1-67C17BA56BF0 Q34291150-ED964AE3-7EEE-41EB-8CAB-E0380EE058F1 Q34721426-6C50CDD0-1F05-4971-8EF9-0278FA6FA2A0 Q35008196-5CDF5498-2391-4907-8A81-EB72198B43E2 Q35065255-A3464E42-D860-48DD-A6E7-FF6DD5242023 Q35147612-AE79C065-0E9E-441F-8780-BBBCCE62A88B Q35498396-C9DDE6EB-F315-4622-9A8E-4B15F3663D55 Q35558494-DADD871B-37C0-422A-AC2D-48EB55D4212B Q35618741-2D4998FF-424F-434E-B5A0-9B5732708250 Q35639805-63D12949-1FC0-40C0-BEEF-EAD5F50820AD Q35749707-919E4E1E-C958-4186-8541-CC47C2676F40 Q35887209-B1C237E6-291C-4056-B140-F2556D490C7C Q35887530-1B5A9134-270F-4E85-8403-AF649DE92C44 Q35942170-21D6CF84-13B9-4453-B268-5113C02B98D1 Q35982768-7825C34E-F3B4-4787-81DF-9E3ADB6A16BE Q36099232-7BC0A155-FF49-41A3-B907-82074E943080 Q36169787-1D9353DC-24A1-482E-8368-57D7955C14E2 Q36256539-42425659-EE45-432D-AEF3-F46ABC14B97B Q36380849-6800DED2-1BC4-418D-9F46-DF3E2F949F71 Q36461527-432C2657-F8E4-45D3-9B18-84E6C11B4175 Q36602847-3AA4C4B2-A2BE-4AE5-AA46-DDD24FBFB8FB Q36691483-F5EDC0D6-60A3-4404-933B-71E7B3CEAA59 Q37321742-6DA8AC0E-9B2B-4385-8344-FB45E30D5CD7 Q37355896-EC432C93-AA6D-4135-8EA9-E6EDE7FD7BEC Q37563813-77A1C4FF-F6AE-455A-BD2F-43B658A6622A Q37591630-509CCC64-6063-4899-9D13-04880256A93C Q37605555-804B517B-9C2A-428C-9DE0-6D22DAD2E830 Q37670193-B6F2D6BE-B6BD-47EE-8ACE-9D2BEEE8D20C Q37713779-D5D6BC43-130F-4294-81E6-1EC73AFA51F8

P2860

Similar herpes zoster incidence across Europe: results from a systematic literature review

http://www.wikidata.org/entity/Q26824836

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Similar herpes zoster incidenc ...... a systematic literature review

@ast

Similar herpes zoster incidenc ...... a systematic literature review

@en

Similar herpes zoster incidenc ...... a systematic literature review

@nl

type

label

Similar herpes zoster incidenc ...... a systematic literature review

@ast

Similar herpes zoster incidenc ...... a systematic literature review

@en

Similar herpes zoster incidenc ...... a systematic literature review

@nl

prefLabel

Similar herpes zoster incidenc ...... a systematic literature review

@ast

Similar herpes zoster incidenc ...... a systematic literature review

@en

Similar herpes zoster incidenc ...... a systematic literature review

@nl

P1433

Q26824836-EB50B5FA-C1E8-4BA3-BB43-C7EC9F3DA366

P1476

Q26824836-F093DECB-5ECD-4633-8264-A688303B0DBE

P2093

Q26824836-57A51004-6DEC-4D31-BCF1-69AD2D0619C6

Q26824836-9B31E7FA-2D7E-4B3E-AFA0-DB311870BD7D

Q26824836-B5BE1013-7D95-4C93-AF28-99FC4F5C6D0D

Q26824836-BFB447B1-F413-4D51-9678-7B44FF4830BB

P275

Q26824836-9D5B1890-2766-4368-828F-C6FF11A38B11

P2860

Q26824836-032FC5D5-1F29-4F27-9CD3-C3913D18B39E

Q26824836-0967EDD3-A460-4FB9-BC7C-C6AA6AA2EE81

Q26824836-0EA3D8CC-6860-43D8-B742-1FE65176F74E

Q26824836-0EEAFE79-5001-46FA-BDC5-0B79B4443C70

Q26824836-26EA0DE6-64E6-44DB-AB5E-4973E211EE5E

Q26824836-2825B54B-D99C-4C18-8122-648B2ECB71A0

Q26824836-2D6EBB44-A61E-44CE-A63E-799836ED2E43

Q26824836-38A57E3C-9CD4-4E54-9791-0A4AADF55558

Q26824836-473B6011-5449-4513-82A0-BB9773D4A634

Q26824836-50FFC1E5-4362-46A1-8F4E-989F2E348C30

P2888

Q26824836-B3D95AFA-2164-4FB6-8522-95CDA3A718B7

P304

Q26824836-9C9BCDDE-2A70-4B62-BAD7-3507CB16FA9C

P31

Q26824836-024E0EC8-C5A5-4D06-B770-0FA21ECE59C7

Q26824836-3e54b78f-4df7-487c-a6fe-ac2095637c15

Q26824836-C8EAEFBE-2D58-4C78-8315-B02B5FE9F5C1

P3181

Q26824836-B1F6BE8C-F3A4-44BF-AA56-BE2A29E33FC3

P356

Q26824836-1D51F946-4CFF-4AFC-A876-E28D96D9CDD6

P407

Q26824836-684DEC5F-F1B6-4AFF-869F-7D1754EEC5F7

P478

Q26824836-20D00E05-FACF-4913-9CE8-8BF12AC4DF14

P5008

Q26824836-BCB3F860-4F7D-422A-B54D-C7FDC7D35D66

P577

Q26824836-03FB2A9C-31D6-40A5-AAC3-DBF10E7B0F1C

P5875

Q26824836-E7C37309-D21D-43EB-8833-001C8FF145E4

P6179

Q26824836-30618A71-E205-44DA-BBE1-1BE4416F59EF

P698

Q26824836-97C01BBD-6232-4793-8ACD-FFB7B61B53CE

P921

Q26824836-629967C7-1A23-45E6-9483-D892CCAB638E

Q26824836-9B09D40A-A81B-411B-8953-A1657C870140

Q26824836-A94F9DE2-FA14-4586-8631-DAECBE2AB1AD

P932

Q26824836-9F97DFEE-7DA4-49A0-AC22-F5F116F95702

P3181

P356

1471-2334-13-170

P1433

BMC Infectious Diseases

P1476

Similar herpes zoster incidenc ...... a systematic literature review

@en

P2093

Ana M Cebrián-Cuenca

http://www.w3.org/2001/XMLSchema#string

Hélène Bricout

http://www.w3.org/2001/XMLSchema#string

Robert W Johnson

http://www.w3.org/2001/XMLSchema#string

Sybil Pinchinat

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS

The incidence of herpes zoster

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

What does epidemiology tell us about risk factors for herpes zoster?

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002

Herpes zoster and postherpetic neuralgia in the elderly.

P2888

1471-2334-13-170

P304

170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2432854

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2334-13-170

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236191288

http://www.w3.org/2001/XMLSchema#string

P6179

1040716472

http://www.w3.org/2001/XMLSchema#string

P698

23574765

http://www.w3.org/2001/XMLSchema#string

P921

Herpesviridae infectious disease

P932

3637114

http://www.w3.org/2001/XMLSchema#string